Connecticut SB 435: AN ACT PROVIDING ACCESS TO PRESCRIPTION BRANDS THAT ARE MEDICALLY NECESSARY FOR PEOPLE DIAGNOSED WITH EPILEPSY.

Status: REF. TO JOINT COMM. ON Public Health (as of 2017-01-19)

State: Connecticut · Session: 2017 · Bill: SB 435

Subjects: Drugs, Epileptics, Pharmaceutical manufacturing companies

Sponsors: b'Slossberg, Gayle S.'

View Connecticut SB 435 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.